Roche's Annual General Meeting, which was held today in Basel, has approved all the Board of Directors' proposals. The 662 shareholders in attendance, representing 143,480,308, or 89.7% of a total of 160,000,000 bearer shares, approved the 2007 Annual Report and financial statements. They also authorised a 35% increase in the gross dividend to 4.60 Swiss francs per share and non-voting equity, the twenty-first dividend increase in as many years. The Annual General Meeting also voted to reduce the term of office of directors from four years to three. Bruno Gehrig, Lodewijk J.R. de Vink, Walter Frey and Andreas Oeri were re-elected to the Board of Directors for a further term of office.
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Comments